Tanzania Pharmaceuticals and Healthcare Report Q2
2013

Tanzania Pharmaceuticals and Healthcare Report Q2 2013

BMI View: The discovery and subsequent suspension of counterfeit antiretroviral drugs (ARVs) produced by the country's first local manufacturer of ARVs highlights the ongoing lack of regulations and drug control mechanisms in place in Tanzania. The country is a market heavily reliant on imports, which bear the greatest risk of counterfeit medication. Combined with the discovery of a production facility producing fake drugs, this has led BMI to believe the road to the availability of quality medicines to address the high burden of HIV and other diseases will be a long one.

Headline Expenditure Projections

• Pharmaceuticals: TZS671.57bn (US$420mn) in 2012 to an anticipated TZS740.18bn (US$450mn) in 2013; +10.2% growth in local currency terms and +7.4% in US dollar terms.
• Healthcare: TZS2.74trn (US$1.72bn) in 2012 to TZS3.13trn (US$1.92bn) in 2013; 14.0% growth in local currency terms and 11.2% in US dollar terms.

• BMI Industry View
  • SWOT Analysis
  • Tanzania Political SWOT
  • Tanzania Economic SWOT
  • Tanzania Business Environment SWOT
  • Pharmaceuticals Risk/Reward Ratings
    • TABLE: MEA Pharmaceuticals And Healthcare Risk/Reward Ratings, Q213
  • Rewards
  • Risks
  • Tanzania - Market Summary
  • Regulatory Regime
  • Intellectual Property Issues
  • Medicine Procurement
  • Industry Trends And Developments
  • Epidemiology
  • Industry Forecast Scenario
  • Pharmaceuticals Market Forecast
    • TABLE: Tanzania Pharmaceutical Sales, Historical Data and Forecasts
  • Healthcare Market Forecast
    • TABLE: Tanzania Healthcare Expenditure Trends, Historical Data and Forecasts
    • TABLE: Tanzania Government Healthcare Expenditure Trends, Historical Data and Forecasts
    • TABLE: Tanzania Private Healthcare Expenditure Trends, Historical Data and Forecasts
  • Macroeconomic Outlook
    • TABLE: Tanzania - Economic Activity
  • Competitive Landscape
  • Local Production
  • Opportunities In Government Financed And Donor Funded Healthcare Sector
  • Demographic Outlook
    • TABLE: Tanzania's Population By Age Group, 1990-2020 ('000)
    • TABLE: Tanzania's Population By Age Group, 1990-2020 (% of total)
    • TABLE: Tanzania's Key Population Ratios, 1990-2020
    • TABLE: Tanzania's Rural And Urban Population, 1990-2020
  • Glossary
  • BMI Methodology
  • How We Generate Our Pharmaceuticals Industry ForecastsPharmaceuticals Risk/Reward Ratings Methodology
  • Ratings Overview
    • TABLE: Pharmaceuticals Business Environment Indicators
  • Weighting
    • TABLE: Weighting Of Components
  • Sources